Anne T. Reutens
Level 4, 99 Commercial Road
Melbourne, VIC 3004, Australia
Melbourne, VIC 3004, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Effects of empagliflozin on cardiac function and cardiorespiratory fitness in people with type 2 diabetes: a randomised controlled trial.
Journal: Cardiovascular diabetology. Endocrinology reports
Published: September 03, 2025
Effect of Empagliflozin on Whole Body, Cardiac, and Renal Sympathetic Outflows in Type 2 Diabetes.
Journal: JACC. Advances
Published: February 25, 2025
An Interactive Web Application for the Statistical Analysis of Continuous Glucose Monitoring Data in Epidemiological Studies.
Journal: Journal of diabetes science and technology
Published: January 13, 2021
Evaluating the efficacy and safety of GKT137831 in adults with type 1 diabetes and persistently elevated urinary albumin excretion: a statistical analysis plan.
Journal: Trials
Published: January 14, 2020
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerations.
Journal: Contemporary clinical trials
Published: November 08, 2018
Acute metabolic and cardiovascular effects of mirabegron in healthy individuals.
Journal: Diabetes, obesity & metabolism
Published: June 14, 2018
Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans.
Journal: Diabetologia
Published: December 10, 2017
Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans.
Journal: Diabetologia
Published: May 21, 2017
Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: January 31, 2017
Cystatin C estimated glomerular filtration rate and all-cause and cardiovascular disease mortality risk in the general population: AusDiab study.
Journal: Nephrology (Carlton, Vic.)
Published: November 26, 2015
A pilot study to examine the tolerability and device preference in type 1 diabetes of insulin aspart administered by InsuJet compared with subcutaneous injection.
Journal: Diabetes technology & therapeutics
Published: November 30, 2013
Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
Journal: Nephrology (Carlton, Vic.)
Published: January 23, 2013
Last Updated: 09/26/2026